Aclarion expands commercial engagement with the london clinic to grow access to nociscan throughout greater london

Established in 1932, the london clinic is the uk's most renowned independent, private hospital payment to aclarion for each nociscan is being increased from the original contract contract extension aligns aclarion and the london clinic with engaging payers to increase access to nociscan for both patients and referring physicians broomfield, co, june 25, 2024 (globe newswire) -- aclarion, inc., (“aclarion” or the “company”) (nasdaq: acon, aconw), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today they are extending their commercial agreement with the prestigious london clinic in london, uk. the contract extension establishes a higher price point for nociscan, engages the london clinic to secure payer coverage decisions from leading private health insurers, and aligns aclarion with the london clinic in expanding access to referring physicians throughout the greater london market.
ACON Ratings Summary
ACON Quant Ranking